BNET Industries

Market Cap:$4.4B
Last Fiscal Year Sales:$1.9B
  • Public
  • US
Dow Jones Description

Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of innovative products in three core therapeutic areas: central nervous system ("CNS"), pain and oncology. In addition to conducting an active research and development program, we market seven proprietary products in the United States and numerous products in various countries throughout Europe and the world. Consistent with our core therapeutic areas, we have aligned our approximately 780-person U.S. field sales and sales management teams by area. We have a sales and marketing organization numbering approximately 400 persons that supports our presence in nearly 20 European countries, including France, the United Kingdom, Germany, Italy and Spain, and certain countries in Africa and the Middle East. For the year ended December 31, 2008, our total revenues and net income were $2.0 billion and $222.5 million, respectively. Our revenues from U.S. and European operations are detailed in Note 18 to our Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K. Our most significant product is PROVIGIL ® (modafinil) Tablets [C-IV], which comprised 51% of our total consolidated net sales for the year ended December 31, 2008, of which 94% was in the U.S. market. For the year ended December 31, 2008, consolidated net sales of PROVIGIL increased 16% over the year ended December 31, 2007. ...

Chief Executive Officer
Frank Baldino PhD
Number of Employees 2,780
Contact Information

145 Brandywine Pkwy

West Chester, Pennsylvania 19380-4245

cephalon.com

1 610 883 5894

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Cephalon Sues Actavis For Infringement Of Patents For Armodafinil Tablets

    12/09/09 - Lawsuit Filed - View Story

  • Soleil Securities Reiterates a 'Buy' Rating on Cephalon CEPH; Treanda to be in Focus Today

    12/07/09 - Bond / Stock Rating - View Story

  • Cephalon sues Teva over sleep drug Nuvigil

    12/03/09 - Lawsuit Filed - View Story

  • Cephalon Files Patent Lawsuit Against Teva

    12/03/09 - Lawsuit Filed - View Story

  • Teva sued by Cephalon over sleep disorder drug: Under the Hatch-Waxman Act, the suit delays...

    12/03/09 - Lawsuit Filed - View Story

  • Cephalon files patent infringement lawsuit against Teva

    12/05/09 - Lawsuit Filed - View Story

  • Sorting Through the Stock Laggards of 2009

    11/27/09 - Bond / Stock Rating - View Story

  • Cephalon hesitates on Ception drug results

    11/23/09 - Merger / Acquisition - View Story

  • RBC Downgrades Cephalon CEPH Following Cinquil Trial Results; Sees 'Little Momentum' Behind the Stock

    11/23/09 - Bond / Stock Rating - View Story

  • Mixed results from Ception, Cephalon on Cinquil

    11/23/09 - Merger / Acquisition - View Story

  • Ception, Cephalon Announce Initial Results Of Phase IIb/III Study Of Cinquil In Pediatric EoE -...

    11/23/09 - Merger / Acquisition - View Story

  • Cephalon and Barr settle patent infringement suit over Fentora

    11/13/09 - Joint Venture / Alliance - View Story

  • Cephalon, Barr Settle Fentora Patent Suit

    11/13/09 - Legal Settlement - View Story

  • Cephalon, Inc. to Webcast R&D Day

    11/04/09 - Merger / Acquisition - View Story

  • Week of Oct. 26, 2009: OXiGENE to Acquire VaxGen; Warner Chilcott Appoints Global R&D President;...

    10/28/09 - Mgmt. Change Entering - Vice President - View Story

  • King Pharma Q3 Profit Falls - Update

    11/05/09 - Financial Announcement - View Story

  • Cephalon snags $30M option on BioAssets

    10/26/09 - Merger / Acquisition - View Story

News & Analysis

analyst and cephalon inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Frank Baldino PhD Chief Executive Officer
Alain Aragues President, Cephalon Europe
Carl Savini Chief Administrative Officer
J. Kevin Buchi Chief Financial Officer
Robert Hrubiec Vice President, Intellectual Property & Chief Counsel, Patent
Gerald J Pappert Executive Vice President
Peter E. Grebow Senior Vice President, Worldwide Technical Operations
Elizabeth Mutisya Vice President, Medical Affairs
Ernest Kelly Vice President, Quality Control, Worldwide
Jeff Myers Vice President, Govt Affairs
John M. Farah Vice President, Intercontinental Operations
Kevin B. Connolly Vice President, Worldwide Prod Planning
Michael Williams Vice President, Worldwide Discovery Research
Natalie Barndt Vice President, Business Development
Robert Grupp Vice President, Corp Communications
Stephen Burns Vice President, Risk Management
Susan Sullman Vice President, Regulatory Affairs Europe
Todd MacLaughlan Vice President, Operations
Candace Steele Senior Director of Product Communications
Jeffrey M. Bonnem Senior Director, Finance Technical Operations
Kiumars Vadiei Director, Medical Affairs
Robert S. Merritt Senior Director, Investor Relations
Scott M. Melville Senior Director, Govt Affairs & Regulatory Counsel
Sheryl L. Williams Senior Director, Prod Communications
Danielle Hall Manager, Recruitment
Jenifer Antonacci Senior Manager, Public Relations
Stacey Beckhardt Senior Manager, Public Relations
Stacey Beckhart Senior Manager, Prod Communications
Yvonne Klemets Wright Manager, Corp Communications
Yvonne Wright Manager, Corp Communications
Colleen A. Hamilton Associate
Merritt Palm Specialty Pharmaceutical Sales Representative
Gail R. Wilensky PhD Director

Board of Directors

Name (plus bio) Position
Charles A. Sanders Board of Directors
Dennis L. Winger Board of Directors
Kevin E. Moley Board of Directors
Martyn D. Greenacre Board of Directors
Vaughn M. Kailian Board of Directors
William P. Egan Board of Directors

Organization Position Status
Cephalon, Inc. Chief Executive Officer Current
Cephalon, Inc. Chairman Current
Bio Advance- The Biotechnology Greenhouse Chairman of the Board Current
Adolor Corporation Board of Directors Current
Orbimed Advisors, LLC Board of Directors Current
Nicox S.A. Director Current
Pharmacopeia Drug Discovery Inc. Board of Directors Current
ViroPharma Incorporated Board of Directors Current
Healthcap Board of Directors Current
The Observers Board of Directors Current
Eisenhower Fellowships Chairman and Chief Executive Officer Former
Cephalon, Inc. President Former
Cephalon, Inc. Founder Former
Cephalon, Inc. Director Former
Temple University Ph.D. In Pharmacology Former

Organization Position Status
Cephalon, Inc. President, Cephalon Europe Current

Mr. Savini joined Cephalon in June 1993 and was Senior Vice President, Human Resources from January 2000 until October 2004 before being named Chief Administrative Officer, and later Executive Vice President in 2006. Prior to that he served as Director, Human Resources and was appointed Vice President, Human Resources in January 1995. Previously, he worked at Bristol-Myers Squibb Company for ten years in positions of increasing responsibility in human resources. Mr. Savini graduated from Pennsylvania State University and received his MBA from La Salle College.

Organization Position Status
Cephalon, Inc. Chief Administrative Officer Current
Personalized Medicine Coalition Executive Vice President & Chief Administrative Officer Current
Eisenhower Fellowships Executive Vice President & Chief Administrative Officer Current
Orbimed Advisors, LLC Executive Vice President & Chief Administrative Officer Current
Cephalon, Inc. Executive Vice President Former
Personalized Medicine Coalition Director, Human Resources Former
Cephalon, Inc. Director, Human Resources Former
Bristol-Myers Squibb Company Human Resources Former
LaSalle College MBA Former
The Pennsylvania State University Graduate Former

Mr. Buchi joined the company as controller in March 1991. He has held several financial positions with the company prior to being appointed senior vice president, finance, and CFO in April 1996 before being named executive vice president & CFO. Between 1985 and 1991, Mr. Buchi served in a number of financial positions with E.I. duPont de Nemours and Company. Mr. Buchi received his masters in management degree from the J.L. Kellogg Graduate School of Management at Northwestern University in 1982, and he is a certified public accountant. Mr. Buchi serves on the board of directors of Lorus Therapeutics, Inc. of Toronto, Canada.

Organization Position Status
Eisenhower Fellowships Executive Vice President & Chief Financial Officer Current
Cephalon, Inc. Chief Financial Officer Current
Cephalon, Inc. Controller Current
Orbimed Advisors, LLC Current
Qdinformation Board of Directors Current
Encysive Pharmaceuticals Inc. Board of Directors Current
Lorus Therapeutics Inc. Director Current
Cephalon, Inc. Senior Vice President, Finance Former
PricewaterhouseCoopers senior auditor and Former
Kellogg School of Management at Northwestern University MBA Former
Northwestern University masters in management degree Former

Organization Position Status
Cephalon, Inc. Vice President, Intellectual Property & Chief Counsel, Patent Current

Organization Position Status
Personalized Medicine Coalition Executive Vice President & General Counsel Current
Cephalon, Inc. Executive Vice President Current
Orbimed Advisors, LLC Executive Vice President & General Counsel Current
Hershey Foods Corporation First Deputy Former
Pennsylvania, Inc. Deputy Attorney General Former
Pennsylvania Supreme Court Former
University of Notre Dame Law School B.A. Former
Villanova University Former
Transportation Financial Insurance Casualties member Former

Organization Position Status
Personalized Medicine Coalition Executive Vice President, Worldwide Technical Operations Current
Orbimed Advisors, LLC Executive Vice President, Worldwide Technical Operations Current
Eisenhower Fellowships Executive Vice President, Worldwide Technical Operations Current
Cephalon, Inc. Senior Vice President, Worldwide Technical Operations Current
Rhone-Poulenc Rorer Pharmaceuticals, Inc. Vice President Former
Cephalon, Inc. Senior Management Former
University of California, Santa Barbara Ph.D. In Chemistry Former
University of California Ph.D. In Chemistry Former

Organization Position Status
Cephalon, Inc. Vice President, Medical Affairs Current

Organization Position Status
Cephalon, Inc. Vice President, Quality Control, Worldwide Current

Organization Position Status
Cephalon, Inc. Vice President, Govt Affairs Current

Organization Position Status
Aeolus Pharmaceuticals, Inc. Vice President, Intercontinental Region of International Pharmaceutical Operations for Cephalon, Inc Current
Cephalon, Inc. Vice President, Intercontinental Operations Current
Aeolus Pharmaceuticals, Inc. Board of Directors Current
Cephalon, Inc. Senior Director, Business Development Former
Aeolus, Inc. Board of Directors Former
University of Maryland Bachelor of Science Degree In Zoology Former

Organization Position Status
Cephalon, Inc. Vice President, Worldwide Prod Planning Current

Organization Position Status
Cephalon, Inc. Vice President, Worldwide Discovery Research Current
Merck Sharp & Dohme Current
Current Biodata Limited Board of Directors Current
University of London D.Sc. In Pharmacology Former

Organization Position Status
Cephalon, Inc. Vice President, Business Development Current

Organization Position Status
Cephalon, Inc. Vice President, Corp Communications Current

Organization Position Status
Cephalon, Inc. Vice President, Risk Management Current

Organization Position Status
Cephalon, Inc. Vice President, Regulatory Affairs Europe Current

Organization Position Status
Cephalon, Inc. Vice President, Operations Current
CIMA Labs Inc. General Manager, Operations Current
Solubest Ltd. Board of Directors Current

Candace Steele is the senior director of product communications for Cephalon, a global biopharmaceutical company. She oversees all U.S. product-related public relations and issues management activity. Candace has worked in the field for more than 15 years with a primary focus on healthcare. She has agency, industry, and not-for-profit experience.

Organization Position Status
Cephalon, Inc. Senior Director of Product Communications Current
Prsa Philly Board of Directors Current

Organization Position Status
Cephalon, Inc. Senior Director, Finance Technical Operations Current
Cephalon, Inc. Senior Director, Finance Technical Operations Former

Organization Position Status
Cephalon, Inc. Director, Medical Affairs Current
Cephalon, Inc. Director, Medical Affairs Former

Organization Position Status
Cephalon, Inc. Senior Director, Investor Relations Current
Cephalon, Inc. Senior Director, Investor Relations Former

Organization Position Status
Cephalon, Inc. Senior Director, Govt Affairs & Regulatory Counsel Current
Cephalon, Inc. Senior Director, Govt Affairs & Regulatory Counsel Former

Organization Position Status
Cephalon, Inc. Senior Director, Prod Communications Current
Cephalon, Inc. Senior Director, Prod Communications Former

Organization Position Status
Cephalon, Inc. Manager, Recruitment Current

Organization Position Status
Cephalon, Inc. Senior Manager, Public Relations Current

Organization Position Status
Cephalon, Inc. Senior Manager, Public Relations Current

Organization Position Status
Cephalon, Inc. Senior Manager, Prod Communications Current

Organization Position Status
Cephalon, Inc. Manager, Corp Communications Current

Organization Position Status
Cephalon, Inc. Manager, Corp Communications Current

Ms. Hamilton has more than 10 years experience as a Human Resource professional with accounting expertise in the biotechnology, medical device and pharmaceutical industries. Previously, Ms. Hamilton acted as a consultant in the role of Director of Human Resources at Purseyn, Inc. Before that, she held the position of Senior Compensation and Benefits Associate at Cephalon, Inc. At Cephalon, she had responsibility for administration of the 401(k) plan, stock option plans, management of the performance management program, compensation and benefits. Prior to Cephalon, she held positions in Accounting and Human Resources, leading to Manager of Human Resources at Orthovita, Inc. While at Orthovita, her responsibilities included staffing, implementing policies and procedures, compliance, compensation and benefits. Earlier in her career, Ms. Hamilton held positions in accounting and finance at Surgical Laser Technologies and AmeriGas. Ms. Hamilton received her Bachelor of Art degree in Accounting from Immaculata University and received a Certificate in Human Resource Management from the Society for Human Resource Management.

Organization Position Status
Biorexis Pharmaceutical Corporation Senior Director, Human Resources Current
Cephalon, Inc. Associate Current
Orthovita, Inc. Manager of Human Resources Former
AmeriGas, Inc. Former
Surgical Laser Technologies, Inc. Former

Merritt Palm, Member-at-Large, is a specialty pharmaceutical sales representative for the CNS division of Cephalon, Inc. Prior to Cephalon, Merritt worked for Johnson and Johnson in sales for the Pain Management Division. She gained marketing and advertising experience at Blakeslee Group in Baltimore handling the North Sails and Douglass Gill global accounts. Merritt was the starboard trimmer aboard the A3 All Women's America's Cup Team in 1995 and following that experience worked in the development department for Young America, the NYYC America's Cup Challenge. She has coached youth sailing teams at the Lauderdale Yacht Club, Bayview Yacht Club and Ram Island Yacht Club and mounted an Olympic Campaign in the Europe Dinghy in 1993.

Organization Position Status
Cephalon, Inc. Specialty Pharmaceutical Sales Representative Current
The Downtown Sailing Center Board of Directors Current
Johnson & Johnson Former

Organization Position Status
The University of North Carolina Trustee Current
marketRx Inc. Current
Feinstein Kean Healthcare Current
Vertex Pharmaceuticals Incorporated Chairman of the Board Current
Venrock Associates Chairman of the Board of Directors Current
Foundation for the National Institutes of Health Chairman, Executive Committee Current
Icagen, Inc. Chairman Current
Project Hope Chairman Former
Drug Safety Alliance, Inc. Board of Directors Current
Icagen, Inc. Board of Directors Current
Kendle International Inc. Director Current
Cephalon, Inc. Board of Directors Current
Genentech, Inc. Director Current
Pharmacopeia Drug Discovery Inc. Board of Directors Current
Radius Ventures, LLC Board of Directors Current
Csis Inc Board of Directors Current
Cardioxyl Pharmaceuticals, Inc. Board of Directors Current
Trimeris, Inc. Director Current
Personalized Medicine Coalition Board of Directors Current
Epiphany Biosciences, Inc. Board of Directors Current
Staffmark Board of Directors Current
Scios, Inc. Director Current
Reata Pharmaceuticals, Inc Board of Directors Current
Vrtx Board of Directors Current
Science & Technology Group CEO Former
Massachusetts General Hospital General Director Former
Harvard Medical School director of Massachusetts General Hospital Former
Massachusetts Gen Hospital General Director Former
Harvard Medical School Professor of Medicine Former
Meredith College trustee Former
Scios Inc. Former
New York Academy of Sciences Chairman Former
Vertex Pharmaceuticals Incorporated Board of Directors Current
Genaera Corporation Board of Directors Former
Reynolds Metals, Inc. Board of Directors Former
Squibb Corporation Board Member Former
Biopure Corporation Director Former
Massachusetts General Hospital Director Former
Squibb Corporation Vice Chairman Former
The University of Texas Southwestern Medical School M.D. Former
The University of Texas Former

Organization Position Status
Applied Biosystems Group Senior Vice President and Chief Financial Officer, Applera Corporation Current
Applera Corporation Chief Financial Officer Current
PerSeptive BioSystems, Inc. CFO & Senior Vice President Current
Applera Corporation Senior Vice President Current
Celera Genomics Current
Celera Diagnostics, LLC Current
Cephalon, Inc. Board of Directors Current
Cell Genesys, Inc. Director Current
Eisenhower Fellowships Board of Directors Current
Personalized Medicine Coalition Board of Directors Current
Personalized Medicine Coalition Member Current
The Cooper Companies, Inc. Chief Financial Officer Former
Chiron Chief Financial Officer Former
Chiron Senior Vice President, Finance and Administration Former
The Cooper Companies, Inc. NA Former
Chiron Finance Former
A.P. Pharma, Inc. Board of Directors Former
Columbia University MBA In Finance Former
Columbia University Bachelor's Degree In History Former
Siena College Bachelor’S Degree In History Former
Applera Corporation Member Former

Organization Position Status
Project Hope and Partners Senior Fellow Current
Cephalon, Inc. Director Current
Quest Diagnostics Incorporated Director Current
UnitedHealth Group Incorporated Board of Directors Current
Lincolnjobs.Com Director Current
Personalized Medicine Coalition Board of Directors Current
Medical Automation Systems, Inc. Director Current
Gentiva Health Services, Inc. Director Current
Health Care Financing Administration Administrator Former

Ambassador Moley currently serves as Chairman of the Board of Project Concern International, a not for profit organization based in San Diego, CA that provides poverty and health care solutions in eleven countries serving over three million people. Ambassador Moley served as the U.S. Permanent Representative to the United Nations and Other International Organizations in Geneva from September 2001 to April 2006. Ambassador Moley also served in the administration of George H.W. Bush as an Assistant Secretary of the U.S. Department of Health and Human Services (HHS) from 1989 to 1992, and as the Deputy Secretary of HHS from 1992 to 1993. In addition to his government service, Ambassador Moley was President and Chief Executive Officer of Integrated Medical Systems Inc. from 1996 to 1998, and was a Senior Vice President of PCS Health Systems, Inc. from 1993 to 1996. Ambassador Moley previously served as a member of the Cephalon Board of Directors from 1994 to 2001.

Organization Position Status
Project.Com Chairman of The Board Current
Personalized Medicine Coalition Board of Directors Current
Eisenhower Fellowships Board of Directors Current
Merge Technologies Incorporated Board of Directors Current
Cephalon, Inc. Board of Directors Current
Integrated Medical Systems, Inc. Chief Executive Officer Former
Integrated Medical Systems, Inc. President Former
PCS Health Systems Senior Vice President Former
Health-Corp Board of Directors Former
Human Services Inc Board of Directors Former

Since July 2004, Mr. Greenacre has served as Chairman of Beijing Med-Pharm Corporation, a pharmaceutical company. Mr. Greenacre also has served since 2002 as Chairman of Life Mist Technologies, Inc., a fire suppression equipment company. From 1997 to 2001, Mr. Greenacre served as Chief Executive Officer and director of Delsys Pharmaceutical Corporation, a formulation and drug delivery system company. From 1993 to 1997, Mr.

Organization Position Status
Life Mist Technologies, Inc. Chairman Current
Curis, Inc. Chair Current
BMP Sunstone Corporation Chairman of the Board Current
Lifemist Chairman Current
Pathway 2 Curis Board of Directors Current
Personalized Medicine Coalition Board of Directors Current
Cephalon, Inc. Board of Directors Current
Acusphere, Inc. Director Current
BMP Sunstone Corporation Committee Member Current
GlaxoSmithKline Plc Chairman Former
Creative BioMolecules, Inc. Director Former
BMP Sunstone Corporation Board of Directors Former
Curis, Inc. Director Former
Orchestra Therapeutics, Inc. Director Former

Organization Position Status
Memory Pharmaceuticals Corp. Interim President and Chief Executive Officer Current
MPM Capital Limited Partnership General Partner Current
Feinstein Kean Healthcare Current
Cerimon Pharmaceuticals, Inc. Chairman Current
ViaCell, Inc. Chairman Current
California Healthcare Institute, Inc. Chairman Current
Elixir Pharmaceuticals, Inc. Chairman Current
Amylin Pharmaceuticals, Inc. Director Current
Nehi Board of Directors Current
Bioventures, Inc. Director Current
Memory Pharmaceuticals Corp. Board of Directors Current
Cephalon, Inc. Board of Directors Current
Windhover Information, Inc. Director Current
Eisenhower Fellowships Board of Directors Current
Nicox S.A. Director Current
Personalized Medicine Coalition Board of Directors Current
The University of Texas at Austin Member Current
Bioventures, Inc. Member Current
COR Therapeutics, Inc. CEO Former
COR Therapeutics, Inc. President Former
Marion Merrell Dow NA Former
Rigid Building Systems Ltd. Co-Chairman Former
Ikaria, Inc. Chairman of The Ikaria Board of Directors Former
Millennium Pharmaceuticals, Inc. Vice Chairman Former
COR Therapeutics, Inc. Director Former
Biotechnology Industry Organization Director Former
Tufts University B.A. Former

Organization Position Status
Wright Equity Partners, LLC Founder and General Partner of Alta Communications Current
J. Devien Capital, LLC Founder and General Partner of Alta Communications Current
Alta Communications Founder Current
Teton Industries Founder and General Partner of Alta Communications Current
Nobska Partners, LLC Limited Partner Current
Venatus Capital Partners Limited Partner Current
Alta Communications General Partner Current
American Franchise Company, LLC Limited Partner Current
8 Wire Capital Partner Current
Johns Creek Partners LLC Partner Current
Fairfield University Trustee Current
University of Pennsylvania Trustee Current
Channelstone Current
Sverica International Current
Black Mountain Equity LLC Current
Pacific Onset Capital LLC Current
Geminus Capital Partners, LLC. Current
CRH plc Board of Directors Current
Cephalon, Inc. Board of Directors Current
Rational Equity Board of Directors Current
Wharton Graduate School of the University of Pennsylvania Board Member Current
Eisenhower Fellowships Board of Directors Current
Fairfield University Board of Directors Current
The Overseer Board of Directors Current
Village Voice Media, Inc. Board of Directors Current
Isabella Stewart Gardner Museum Board of Directors Current
Personalized Medicine Coalition Board of Directors Current
Fairfield University Trustee Current
Isabella Stewart Gardner Museum Trustee Current
Wharton Graduate School of the University of Pennsylvania President Former
Burr, Egan, Deleage & Co. Founder Former
TA Associates, Inc. Partner Former
Wharton School, University of Pennsylvania MBA Former
Wharton Graduate School of the University of Pennsylvania MBA Former
Fairfield University BA Former
Fairfield University Degree In Economics Former

Executive News

  • The Next 100 Days: Some Final Hurdles to Health Reform

    Reuters - 9/02/09 - View Story

  • The Next 100 Days: Some Final Hurdles to Health Reform

    PR Newswire - 9/02/09 - View Story

  • CVS, Rite Aid sue over alleged delayed competition

    Providence Business News - 9/02/09 - View Story

  • CVS, Rite Aid sue over alleged delayed

    Providence Business News - 9/01/09 - View Story

  • Business news in brief

    Philadelphia Inquirer - 8/29/09 - View Story

  • Judge rejects Cephalon shareholder suit

    Philadelphia Inquirer - 8/28/09 - View Story

  • Drug, Biotech Research Spending Hangs Tough

    BusinessWeek - 8/27/09 - View Story

  • As rumors swirl, seniors demanding answers on health reform

    Chicago Tribune - 8/12/09 - View Story

  • Cephalon completes acquisition of Arana for $207 million

    SmartBrief - 8/11/09 - View Story

  • Room for Debate: What Happened to a Public Health Plan?

    New York Times - 8/10/09 - View Story

  • Cephalon completes Arana purchase

    Biz Journals - 8/10/09 - View Story

  • Cephalon Completes Acquisition of Arana Therapeutics

    PR Newswire - 8/10/09 - View Story

  • Cephalon completes Arana purchase

    Philadelphia Business Journal - 8/10/09 - View Story

advertisement
     CEPH $59.13 +0.19 (0.32% )
Average Volume 2,233,840
Shares Outstanding 74.66M
Market Cap 4.4B
Year High 81.35
Year Low 52.55
Earnings Per Share 3.30
P/E Ratio 17.92
Dividend N/A
Yield N/A
advertisement